Important information for users of Emerade (adrenaline autoinjector)
The makers of Emerade have advised there is a risk of needle blockage leading to Emerade failing to deliver a dose of adrenaline.
The risk is low, 2.3 in every thousand pens, however patients are advised carry two in-date pens with them at all times.
The product is not being recalled. Published: 16 July 2019